Sponsors (4)
The bill directs federal support toward earlier detection, research, outreach, and transparency to improve care and equity for women with uterine fibroids and related conditions, while requiring new taxpayer funding and risking uneven implementation, administrative burdens, provider capacity strain, and privacy or follow-up gaps.
Women at risk for or living with uterine fibroids will get earlier detection and diagnosis through funded screening, standardized evidence-based detection strategies, imaging support, public awareness campaigns, and patient navigation.
Low-income and underserved women will face reduced barriers to care because grant-funded outreach, paid screening, facilitation of access to healthcare settings, and navigation services target historically hard-to-reach populations.
Health care providers, hospitals, and state programs will receive evidence-informed practices, technical guidance, and state-level support that can improve care coordination and program effectiveness over time.
Taxpayers may face increased federal spending to fund research, grant programs, screening services, and report preparation.
If funding is limited or uneven, some states and communities will be left without expanded screening, outreach, or services, producing unequal access across populations.
The bill lacks specified funding amounts, clear eligibility criteria, and timelines for grants, so programs may never be funded or useful and states could incur wasted planning costs.
Based on analysis of 5 sections of legislative text.
Authorizes HHS to research uterine fibroid detection and treatments, create evidence-based strategies, award state grants for screening and awareness, and require biennial public reports.
Introduced July 30, 2025 by Angela Deneece Alsobrooks · Last progress July 30, 2025
Directs the Department of Health and Human Services to research and develop evidence-based strategies to improve early detection and intervention for uterine fibroids and to make those strategies available to states. Authorizes HHS to award grants to states for screening, imaging payments, patient navigation, public awareness campaigns, and to support state-level research (including clinical trials) on disparities in pain control and intrauterine conditions like Asherman’s Syndrome. Requires the HHS Secretary to report publicly to Congress on program results and research findings beginning no later than two years after the first grants are awarded and every two years after that. The bill creates grant authorities and reporting duties but does not specify funding amounts, eligibility criteria, or detailed implementation timelines.